146 related articles for article (PubMed ID: 37984359)
41. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
Etulain J; Mena HA; Negrotto S; Schattner M
Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
[TBL] [Abstract][Full Text] [Related]
42. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
[TBL] [Abstract][Full Text] [Related]
43. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.
Quinton TM; Kim S; Derian CK; Jin J; Kunapuli SP
J Biol Chem; 2004 Apr; 279(18):18434-9. PubMed ID: 14973136
[TBL] [Abstract][Full Text] [Related]
44. Stimulation of naïve monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only.
Nieuwenhuizen L; Falkenburg WJ; Schutgens RE; Roosendaal G; van Veghel K; Biesma DH; Lafeber FP
Scand J Immunol; 2013 May; 77(5):339-49. PubMed ID: 23421536
[TBL] [Abstract][Full Text] [Related]
45. Integration of endothelial protease-activated receptor-1 inflammatory signaling by ubiquitin.
Grimsey NJ; Trejo J
Curr Opin Hematol; 2016 May; 23(3):274-9. PubMed ID: 26845544
[TBL] [Abstract][Full Text] [Related]
46. Thrombin: A Pivotal Player in Hemostasis and Beyond.
Larsen JB; Hvas AM
Semin Thromb Hemost; 2021 Oct; 47(7):759-774. PubMed ID: 34154000
[TBL] [Abstract][Full Text] [Related]
47. Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.
Tillery LC; Epperson TA; Eguchi S; Motley ED
Exp Biol Med (Maywood); 2016 Mar; 241(6):569-80. PubMed ID: 26729042
[TBL] [Abstract][Full Text] [Related]
48. Role of protease-activated receptors in the vascular system.
Hirano K; Kanaide H
J Atheroscler Thromb; 2003; 10(4):211-25. PubMed ID: 14566084
[TBL] [Abstract][Full Text] [Related]
49. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
50. Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1.
Bae JS; Yang L; Rezaie AR
J Biol Chem; 2010 Nov; 285(45):34803-12. PubMed ID: 20826780
[TBL] [Abstract][Full Text] [Related]
51. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1.
Riewald M; Kravchenko VV; Petrovan RJ; O'Brien PJ; Brass LF; Ulevitch RJ; Ruf W
Blood; 2001 May; 97(10):3109-16. PubMed ID: 11342437
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic potential of protease-activated receptor-1 antagonists.
Derian CK; Maryanoff BE; Zhang HC; Andrade-Gordon P
Expert Opin Investig Drugs; 2003 Feb; 12(2):209-21. PubMed ID: 12556215
[TBL] [Abstract][Full Text] [Related]
53. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
54. Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin.
Ofosu FA; Dewar L; Craven SJ; Song Y; Cedrone A; Freedman J; Fenton JW
J Biol Chem; 2008 Oct; 283(40):26886-93. PubMed ID: 18682394
[TBL] [Abstract][Full Text] [Related]
55. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
[TBL] [Abstract][Full Text] [Related]
56. Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.
Zolotoff C; Puech C; Roche F; Perek N
Sci Rep; 2022 Jul; 12(1):12305. PubMed ID: 35853902
[TBL] [Abstract][Full Text] [Related]
57. A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.
Gorbacheva LR; Kiseleva EV; Savinkova IG; Strukova SM
Biochemistry (Mosc); 2017 Jul; 82(7):778-790. PubMed ID: 28918742
[TBL] [Abstract][Full Text] [Related]
58. Thrombin's central role in angiogenesis and pathophysiological processes.
Tsopanoglou NE; Maragoudakis ME
Eur Cytokine Netw; 2009 Dec; 20(4):171-9. PubMed ID: 20167556
[TBL] [Abstract][Full Text] [Related]
59. Thrombin in complex with dabigatran can still interact with PAR-1 via exosite-I and instigate loss of vascular integrity.
Dólleman SC; Agten SM; Spronk HMH; Hackeng TM; Bos MHA; Versteeg HH; van Zonneveld AJ; de Boer HC
J Thromb Haemost; 2022 Apr; 20(4):996-1007. PubMed ID: 35037739
[TBL] [Abstract][Full Text] [Related]
60. Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells.
Chang LH; Chen CH; Huang DY; Pai HC; Pan SL; Teng CM
J Cell Physiol; 2011 Apr; 226(4):1060-8. PubMed ID: 20857420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
